• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Nitric Oxide Restores Transfusion Efficacy


DURHAM, N.C. -- The oxygen-transporting efficacy of stored blood begins to decay almost immediately but adding nitric oxide may keep it fresh, two groups of researchers here said.

DURHAM, N.C., Oct. 9 -- The oxygen-transporting efficacy of stored blood begins to decay almost immediately but adding nitric oxide may keep it fresh, two groups of researchers here said.

Because stored red blood cells become deficient in nitric oxide, which limits their ability to get oxygen to tissues that need it, transfusions of banked blood may do more harm than good, the Duke researchers here reported online in the Proceedings of the National Academy of Sciences.

But adding nitric oxide - at least in animals -- restores the cells' ability to dilate blood vessels and oxygenate tissue, according to Jonathan Stamler, M.D., and colleagues.

The finding opens to the door to possible interventions that would improve the efficacy of transfusions, they said. "Blood can be life saving, only it is not helping the way we had hoped and in many cases it may be making things worse," added Dr. Stamler.

"In principle," he added, "we now have a solution to the nitric oxide problem -- we can put it back -- but it needs to be proven in a clinical trial."

In a second paper in the journal, Tim McMahon, M.D., Ph.D., and Duke colleagues, reported on exactly how quickly the deterioration of banked blood occurs.

"We saw clear indications of nitric oxide depletion within the first three hours," Dr. McMahon said.

That implies that even so-called fresh blood may already have what he called "adverse biological characteristics."

The two research groups are independent but related, a Duke spokesman said. Dr. McMahon is a former student of Dr. Stamler who now has his own lab at Duke.

Dr. Stamler and colleagues, suspecting that a deficiency in nitric oxide was responsible for higher rates of death and ischemia among transfusion recipients, focused their attention on a molecule called S-nitrohemoglobin. S-nitrohemoglobin is a derivative of hemoglobin that carries nitric oxide.

In vitro studies showed that levels of S-nitrohemoglobin declined rapidly in stored red blood cells, Dr. Stamler and colleagues said, with a 70% drop in the first day -- a difference from fresh blood that was significant at P

"Nitric oxide opens up the tiny blood vessels, allowing red blood cells to pass and deliver oxygen," he said. "If the blood vessels cannot open, the red blood cells back up in the vessel and tissues go without oxygen."

"The result can be a heart attack or even death," he said.

Dr. McMahon and colleagues tested stored human blood cells for a range of parameters and - like Dr. Stamler's group - they observed declines in S-nitrohemoglobin and related molecules that were significant at P

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2024 MJH Life Sciences

All rights reserved.